Relations of Neuropeptide Y and Heme Oxygenase-1 Expressions with Fetal Brain Injury in Rats with Intrahepatic Cholestasis of Pregnancy

Overview

Journal Acta Cir Bras

Specialty General Surgery

Date 2019 May 9

PMID 31066785

Citations 3

Authors

Hongxia Li

Bofeng Liu

Chunyan Gu

Xiao Zeng

Yali Liu

Susu Zhang

Haiye Gong

Yong Shao

Zhenwei Yao

Ruifang An

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the relations of neuropeptide Y (NPY) and heme oxygenase-1 (HO-1) expressions with fetal brain injury in rats with intrahepatic cholestasis of pregnancy (ICP).

Methods: Sixty rats pregnant for 15 days were randomly divided into experimental and control groups. The ICP model was established in experimental group. On the 21st day, the blood biochemical test, histopathological examination of pregnant rat liver and fetal brain tissues and immunohistochemical analysis of fetal rat brain tissues were performed.

Results: On the 21st day, the alanineaminotransferase, aspartate aminotransferase and total bile acid levels in experimental group were significantly higher than control group (P<0.01). Compared with control group, there was obvious vacuolar degeneration in pregnant rat liver tissue and fetal brain tissue in experimental group. NPY expression in fetal brain tissue was negative in control group and positive in experimental group. HO-1 expression in fetal brain tissue was strongly positive in control group and positive in experimental group. There was significant difference of immunohistochemical staining optical density between two groups (P<0.01).

Conclusion: In fetal brain of ICP rats, the NPY expression is increased, and the HO-1 expression is decreased, which may be related to the fetal brain injury.

Citing Articles

Maternal intrahepatic cholestasis of pregnancy and neurodevelopmental conditions in offspring: A population-based cohort study of 2 million Swedish children.

Chen S, Ahlqvist V, Sjoqvist H, Stephansson O, Magnusson C, Dalman C PLoS Med. 2024; 21(1):e1004331.

PMID: 38227577 PMC: 10790993. DOI: 10.1371/journal.pmed.1004331.

Cellular and mitochondrial taurine depletion in bile duct ligated rats: a justification for taurine supplementation in cholestasis/cirrhosis.

Najibi A, Rezaei H, Kumar Manthari R, Niknahad H, Jamshidzadeh A, Farshad O Clin Exp Hepatol. 2023; 8(3):195-210.

PMID: 36685263 PMC: 9850306. DOI: 10.5114/ceh.2022.119216.

Effect of cholestasis and NeuroAid treatment on the expression of Bax, Bcl-2, Pgc-1α and Tfam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats.

Nasehi M, Torabinejad S, Hashemi M, Vaseghi S, Zarrindast M Metab Brain Dis. 2019; 35(1):183-192.

PMID: 31773435 DOI: 10.1007/s11011-019-00508-y.

References

Ryter S, Tyrrell R . The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med. 2001; 28(2):289-309. DOI: 10.1016/s0891-5849(99)00223-3. View

Chen S, Cheung R . Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats. Neuroscience. 2003; 116(1):119-26. DOI: 10.1016/s0306-4522(02)00576-6. View

Jarvisalo M, Jartti L, Karvonen M, Pesonen U, Koulu M, Marniemi J . Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y. Atherosclerosis. 2003; 167(2):319-26. DOI: 10.1016/s0021-9150(03)00017-0. View

Drakulich D, Walls A, Toews M, Hexum T . Neuropeptide Y receptor-mediated sensitization of ATP-stimulated inositol phosphate formation. J Pharmacol Exp Ther. 2003; 307(2):559-65. DOI: 10.1124/jpet.103.053082. View

Protas L, Qu J, Robinson R . Neuropeptide y: neurotransmitter or trophic factor in the heart?. News Physiol Sci. 2003; 18:181-5. DOI: 10.1152/nips.01437.2003. View

Donoso M, Miranda R, Irarrazaval M, Huidobro-Toro J . Neuropeptide Y is released from human mammary and radial vascular biopsies and is a functional modulator of sympathetic cotransmission. J Vasc Res. 2004; 41(5):387-99. DOI: 10.1159/000080900. View

Vallejo M, Briz O, Serrano M, Monte M, Marin J . Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy. J Hepatol. 2006; 44(6):1150-7. DOI: 10.1016/j.jhep.2005.09.017. View

Ewing J, Maines M . Regulation and expression of heme oxygenase enzymes in aged-rat brain: age related depression in HO-1 and HO-2 expression and altered stress-response. J Neural Transm (Vienna). 2006; 113(4):439-54. DOI: 10.1007/s00702-005-0408-z. View

Liu J, Zhao J, Di Y, Guo X, Zhai G, Huang X . The dynamic changes of plasma neuropeptide y and neurotensin and their role in regulating cerebral hemodynamics in neonatal hypoxic-ischemic encephalopathy. Am J Perinatol. 2007; 24(7):435-40. DOI: 10.1055/s-2007-985047. View

10.

Hodges G, Jackson D, Mattar L, Johnson J, Shoemaker J . Neuropeptide Y and neurovascular control in skeletal muscle and skin. Am J Physiol Regul Integr Comp Physiol. 2009; 297(3):R546-55. PMC: 2739783. DOI: 10.1152/ajpregu.00157.2009. View

11.

Pauli-Magnus C, Meier P, Stieger B . Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy. Semin Liver Dis. 2010; 30(2):147-59. DOI: 10.1055/s-0030-1253224. View

12.

Wang C, Chen X, Zhou S, Li X . Impaired fetal adrenal function in intrahepatic cholestasis of pregnancy. Med Sci Monit. 2011; 17(5):CR265-71. PMC: 3539589. DOI: 10.12659/msm.881766. View

13.

Wong R, Zhao H, Stevenson D . A deficiency in haem oxygenase-1 induces foetal growth restriction by placental vasculature defects. Acta Paediatr. 2012; 101(8):827-34. DOI: 10.1111/j.1651-2227.2012.02729.x. View

14.

Colin-Gonzalez A, Orozco-Ibarra M, Chanez-Cardenas M, Rangel-Lopez E, Santamaria A, Pedraza-Chaverri J . Heme oxygenase-1 (HO-1) upregulation delays morphological and oxidative damage induced in an excitotoxic/pro-oxidant model in the rat striatum. Neuroscience. 2012; 231:91-101. DOI: 10.1016/j.neuroscience.2012.11.031. View

15.

Yu L, Ding Y, Huang T, Huang X . Effect of bile Acid on fetal lung in rat model of intrahepatic cholestasis of pregnancy. Int J Endocrinol. 2014; 2014:308274. PMC: 3980923. DOI: 10.1155/2014/308274. View

16.

Kaartokallio T, Klemetti M, Timonen A, Uotila J, Heinonen S, Kajantie E . Microsatellite polymorphism in the heme oxygenase-1 promoter is associated with nonsevere and late-onset preeclampsia. Hypertension. 2014; 64(1):172-7. DOI: 10.1161/HYPERTENSIONAHA.114.03337. View

17.

Brouwers L, Koster M, Page-Christiaens G, Kemperman H, Boon J, Evers I . Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol. 2014; 212(1):100.e1-7. DOI: 10.1016/j.ajog.2014.07.026. View

18.

Askenazi D, Halloran B, Patil N, Keeling S, Saeidi B, Koralkar R . Genetic polymorphisms of heme-oxygenase 1 (HO-1) may impact on acute kidney injury, bronchopulmonary dysplasia, and mortality in premature infants. Pediatr Res. 2015; 77(6):793-8. PMC: 4439308. DOI: 10.1038/pr.2015.44. View

19.

Parizek A, Duskova M, Vitek L, Sramkova M, Hill M, Adamcova K . The role of steroid hormones in the development of intrahepatic cholestasis of pregnancy. Physiol Res. 2015; 64(Suppl 2):S203-9. DOI: 10.33549/physiolres.933117. View

20.

Dixon P, Williamson C . The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol. 2016; 40(2):141-53. DOI: 10.1016/j.clinre.2015.12.008. View